Lucid Diagnostics Inc. Q4 2025 Earnings Call Summary

What: Lucid Diagnostics Inc. reported Q4 2025 revenue of **$14.1 million**, a **26%** increase from the same period last year.
Why: The growth was driven by strong demand for the company's Lucity system, a point-of-care diagnostic platform.
Signal: Lucid Diagnostics Inc. narrowed its net loss to **$-1.5 million**, down from **$-3.5 million** in Q4 2024.
Target: The company maintained its guidance for 2026 revenue growth, targeting **$60 million**, a **50%** increase from 2025.
Risk: The company faces increased competition in the point-of-care diagnostic market, which may impact future growth.